Jpmorgan Chase & CO Asensus Surgical, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ASXC
# of Institutions
50Shares Held
39.8MCall Options Held
12.4KPut Options Held
0-
Beryl Capital Management LLC Redondo Beach, CA14.5MShares$5.08 Million1.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$4.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.47MShares$1.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$874,3530.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2MShares$700,0000.04% of portfolio
About ASENSUS SURGICAL, INC.
- Ticker ASXC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 236,719,008
- Market Cap $82.9M
- Description
- Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...